002287 奇正藏药
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入403,01510.39%2,337,9702,045,1522,044,7891,770,486
减:营业总成本323,3607.83%1,858,5031,628,6741,555,9731,374,825
    其中:营业成本74,4579.45%418,375323,315324,140265,342
               财务费用14,33338.84%53,86750,22939,92219,476
               资产减值损失879--(1,179)(1,401)(2,454)(16,061)
公允价值变动收益18,669-33.61%105,13737,074(3,429)20,693
投资收益(3,334)-132.42%(4,822)28,780(33,652)305,893
    其中:对联营企业和合营企业的投资收益(1,582)138.59%(6,466)1,888(54,907)293,361
营业利润98,769-12.87%657,025646,383521,541790,206
利润总额89,028-21.42%646,244644,413519,202787,914
减:所得税费用13,934-4.55%64,87565,23549,56077,088
净利润75,095-23.91%581,370579,178469,643710,826
减:非控股权益(585)-147.45%(911)(2,021)(2,900)(5,050)
股东净利润75,680-22.35%582,281581,199472,542715,876

市场价值指针
每股收益 (元) *0.143-22.47%1.0981.0970.8921.354
每股派息 (元) *----0.6000.4800.3900.590
每股净资产 (元) *7.3255.41%7.4076.7646.0395.723
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容